Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer (TULIP)

This study has been terminated.
(Insufficient recruits)
Sponsor:
Collaborators:
Deakin University
Peter MacCallum Cancer Centre, Australia
Information provided by (Responsible Party):
Barwon Health
ClinicalTrials.gov Identifier:
NCT01486459
First received: December 4, 2011
Last updated: August 14, 2014
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)